Literature DB >> 12883042

Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy.

A Craig Lockhart1, Rommel G Tirona, Richard B Kim.   

Abstract

The ATP-binding cassette (ABC) transporters belong to the largest known transporter gene family and translocate a variety of substrates including chemotherapy agents. ABC multidrug transporter expression has been implicated in tumor cell resistance to anticancer therapy, altered disposition of chemotherapy drugs, and associated chemotherapy toxicity. More recently, genetic heterogeneity has been described in a number of the ABC transporter genes, including ABC transporters that contribute to the pharmacokinetics and/or pharmacodynamics of chemotherapy drugs. The role of these transporters and their naturally occurring genetic polymorphisms in cancer and chemotherapy is reviewed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12883042

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  25 in total

1.  Drug efflux by breast cancer resistance protein is a mechanism of resistance to the benzimidazole insulin-like growth factor receptor/insulin receptor inhibitor, BMS-536924.

Authors:  Xiaonan Hou; Fei Huang; Joan M Carboni; Karen Flatten; Yan W Asmann; Cynthia Ten Eyck; Takeo Nakanishi; Jennifer D Tibodeau; Douglas D Ross; Marco M Gottardis; Charles Erlichman; Scott H Kaufmann; Paul Haluska
Journal:  Mol Cancer Ther       Date:  2011-01       Impact factor: 6.261

Review 2.  New agents in the arsenal to fight castrate-resistant prostate cancer.

Authors:  Erin E Ezzell; Kuang S Chang; Benjamin J George
Journal:  Curr Oncol Rep       Date:  2013-06       Impact factor: 5.075

Review 3.  Disrupting P-glycoprotein function in clinical settings: what can we learn from the fundamental aspects of this transporter?

Authors:  Francisco S Chung; Jayson S Santiago; Miguel Francisco M De Jesus; Camille V Trinidad; Melvin Floyd E See
Journal:  Am J Cancer Res       Date:  2016-08-01       Impact factor: 6.166

Review 4.  The ATP-binding cassette transporter ABCA2 as a mediator of intracellular trafficking.

Authors:  J T Mack; V Beljanski; K D Tew; D M Townsend
Journal:  Biomed Pharmacother       Date:  2006-08-31       Impact factor: 6.529

5.  Different Efflux Transporter Affinity and Metabolism of 99mTc-2-Methoxyisobutylisonitrile and 99mTc-Tetrofosmin for Multidrug Resistance Monitoring in Cancer.

Authors:  Masato Kobayashi; Takafumi Tsujiuchi; Yuya Okui; Asuka Mizutani; Kodai Nishi; Takeo Nakanishi; Ryuichi Nishii; Kazuki Fukuchi; Ikumi Tamai; Keiichi Kawai
Journal:  Pharm Res       Date:  2018-11-29       Impact factor: 4.200

6.  Aberrant regulation of the MRP3 gene in non-small cell lung carcinoma.

Authors:  Christopher M Mahaffey; Nichole C Mahaffey; William Holland; Hongqiao Zhang; David R Gandara; Philip C Mack; Henry Jay Forman
Journal:  J Thorac Oncol       Date:  2012-01       Impact factor: 15.609

7.  Pharmacogenomic modeling of circulating tumor and invasive cells for prediction of chemotherapy response and resistance in pancreatic cancer.

Authors:  Kenneth H Yu; Mark Ricigliano; Manuel Hidalgo; Ghassan K Abou-Alfa; Maeve A Lowery; Leonard B Saltz; Joseph F Crotty; Kristen Gary; Brandon Cooper; Rena Lapidus; Mariola Sadowska; Eileen M O'Reilly
Journal:  Clin Cancer Res       Date:  2014-08-08       Impact factor: 12.531

8.  Multidrug-resistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinoma.

Authors:  Christopher M Mahaffey; Hongqiao Zhang; Alessandra Rinna; William Holland; Philip C Mack; Henry Jay Forman
Journal:  Free Radic Biol Med       Date:  2009-04-05       Impact factor: 7.376

9.  Phenotypic drug profiling in droplet microfluidics for better targeting of drug-resistant tumors.

Authors:  S Sarkar; N Cohen; P Sabhachandani; T Konry
Journal:  Lab Chip       Date:  2015-12-07       Impact factor: 6.799

10.  Influence of ABCB1 polymorphisms and haplotypes on tacrolimus nephrotoxicity and dosage requirements in children with liver transplant.

Authors:  Ahmed F Hawwa; Patrick J McKiernan; Michael Shields; Jeff S Millership; Paul S Collier; James C McElnay
Journal:  Br J Clin Pharmacol       Date:  2009-09       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.